WIC
GILD icon

Woodmont Investment Counsel’s Gilead Sciences GILD Stock Holding History

Woodmont Investment Counsel’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-1,604
Closed -$127K – 354
2016
Q3 		$127K Buy
+1,604
New +$130K 0.04% 193
2016
Q2 		– Sell
-1,500
Closed -$138K – 290
2016
Q1 		$138K Hold
1,500
– – 0.04% 187
2015
Q4 		$152K Hold
1,500
– – 0.04% 192
2015
Q3 		$147K Hold
1,500
– – 0.04% 192
2015
Q2 		$176K Buy
+1,500
New +$164K 0.05% 178

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Woodmont Investment Counsel's GILD Position: Q4 2016 in Review

Woodmont Investment Counsel sold out of Gilead Sciences (GILD) in Q4 2016, closing a stake of 1,604 shares — an estimated $127K sold.

Woodmont Investment Counsel first reported a position in GILD in Q2 2015 and held it in 5 quarters. The position peaked at $176K in Q2 2015. 1,573 funds tracked by Wall St. Rank hold GILD as of Q4 2016.

  • Woodmont Investment Counsel reported no remaining Gilead Sciences position as of Q4 2016 after selling out during the quarter.
  • Woodmont Investment Counsel sold 1,604 Gilead Sciences shares in Q4 2016, an estimated $127K.
  • Woodmont Investment Counsel first reported a position in Gilead Sciences in Q2 2015 and held it in 5 quarters.
  • Woodmont Investment Counsel's Gilead Sciences position peaked at $176K in Q2 2015.
  • 1,573 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2016.

Based on Woodmont Investment Counsel's 13F filing for Q4 2016, filed 13 Feb 2017.